$2.04
0.010.49%
At close: -
$2.09
0.052.57%
After Hours: 6:46 PM EDT
Intensity Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Intensity Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
INTS | Intensity Therapeutics | -$0.34 | -$0.28 | — | — | $0.00 | — | — | — | 05/08/2025 | Get Alert |
INTS | Intensity Therapeutics | -$0.12 | -$0.23 | -$0.22 | 4.35% | $0.00 | — | $0.00 | — | 03/13/2025 | Get Alert |
INTS | Intensity Therapeutics | -$0.17 | -$0.30 | -$0.25 | 16.67% | $0.00 | — | $0.00 | — | 11/13/2024 | Get Alert |
INTS | Intensity Therapeutics | -$1.43 | -$0.32 | -$0.36 | -12.50% | $0.00 | — | $0.00 | — | 08/08/2024 | Get Alert |
INTS | Intensity Therapeutics | -$0.39 | — | -$0.34 | — | — | — | $0.00 | — | 05/09/2024 | Get Alert |
INTS | Intensity Therapeutics | — | -$0.18 | -$0.12 | 33.33% | — | — | $0.00 | — | 03/14/2024 | Get Alert |
INTS | Intensity Therapeutics | -$0.52 | -$0.09 | -$0.17 | -88.89% | $0.00 | — | $0.00 | — | 11/13/2023 | Get Alert |
INTS | Intensity Therapeutics | — | -$0.40 | -$0.79 | -97.50% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-03-13 | $-0.22 | $-0.23 | 4.35 % |
Q3 | 2024-11-13 | $-0.25 | $-0.30 | 16.7 % |
Q2 | 2024-08-08 | $-0.36 | $-0.32 | -12.5 % |
Q4 | 2024-03-14 | $-0.12 | $-0.18 | 33.3 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Intensity Therapeutics (INTS) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 13, 2025 for Q4.
The Actual EPS was $-0.22, which beat the estimate of $-0.23.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.